1. Home
  2. NTRB vs ELUT Comparison

NTRB vs ELUT Comparison

Compare NTRB & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRB
  • ELUT
  • Stock Information
  • Founded
  • NTRB 2016
  • ELUT 2015
  • Country
  • NTRB United States
  • ELUT United States
  • Employees
  • NTRB N/A
  • ELUT N/A
  • Industry
  • NTRB Industrial Specialties
  • ELUT Medical Specialities
  • Sector
  • NTRB Health Care
  • ELUT Health Care
  • Exchange
  • NTRB Nasdaq
  • ELUT Nasdaq
  • Market Cap
  • NTRB 82.3M
  • ELUT 88.4M
  • IPO Year
  • NTRB N/A
  • ELUT 2020
  • Fundamental
  • Price
  • NTRB $6.44
  • ELUT $2.09
  • Analyst Decision
  • NTRB Buy
  • ELUT Strong Buy
  • Analyst Count
  • NTRB 1
  • ELUT 2
  • Target Price
  • NTRB $13.00
  • ELUT $8.00
  • AVG Volume (30 Days)
  • NTRB 192.4K
  • ELUT 29.0K
  • Earning Date
  • NTRB 09-05-2025
  • ELUT 08-14-2025
  • Dividend Yield
  • NTRB N/A
  • ELUT N/A
  • EPS Growth
  • NTRB N/A
  • ELUT N/A
  • EPS
  • NTRB N/A
  • ELUT N/A
  • Revenue
  • NTRB $2,398,437.00
  • ELUT $23,683,000.00
  • Revenue This Year
  • NTRB $560.75
  • ELUT $20.10
  • Revenue Next Year
  • NTRB $588.39
  • ELUT $85.89
  • P/E Ratio
  • NTRB N/A
  • ELUT N/A
  • Revenue Growth
  • NTRB 18.92
  • ELUT N/A
  • 52 Week Low
  • NTRB $2.98
  • ELUT $1.61
  • 52 Week High
  • NTRB $9.42
  • ELUT $5.12
  • Technical
  • Relative Strength Index (RSI)
  • NTRB 39.08
  • ELUT 52.40
  • Support Level
  • NTRB $6.05
  • ELUT $1.96
  • Resistance Level
  • NTRB $6.67
  • ELUT $2.30
  • Average True Range (ATR)
  • NTRB 0.44
  • ELUT 0.14
  • MACD
  • NTRB -0.04
  • ELUT 0.01
  • Stochastic Oscillator
  • NTRB 22.54
  • ELUT 45.03

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Share on Social Networks: